GSK - Zantac Verdict: Jury Finds No Link To Colon Cancer In Initial Trial GSK And Boehringer Prevail In First Zantac Cancer Lawsuit | Benzinga
A Chicago jury rejected an Illinois woman’s claim that the discontinued heartburn drug Zantac caused her colon cancer. This case is the first of thousands of similar lawsuits.
The jury in Cook County, Illinois, found that Angela Valadez, an 89-year-old Illinois resident, did not prove her cancer was linked to her Zantac use.
Related: GSK Concealed Risk Associated With Discontinued Heart Burn Drug Zantac, Whistleblower Lawsuit Claims.
Valadez alleged that her cancer resulted from taking over-the-counter Zantac and its generic versions from 1995 to 2014.
Her attorneys sought $640 million for her suffering, arguing ...